SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1473)10/15/1998 3:57:00 PM
From: Steve Harmon  Respond to of 2742
 
We already know that Cistron's 2 officers and Bluestone Capital are happy.

Their value has been enhanced greatly!

I thought the goal of the Bluestone Capital agreement 13 months ago was to enhance shareholder value?



To: Walter Morton who wrote (1473)10/16/1998 8:27:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
When is the 4 million share buyback going to occur which would easily put Cistron's shares above $1 and keep it there?



To: Walter Morton who wrote (1473)10/16/1998 8:51:00 AM
From: Steve Harmon  Respond to of 2742
 
Cistron is currently priced as if the PMC deal is dead.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News